2Khanna D. Diagnosis and treatment of systemic and localized scleroderma [J]. Expert Rev Dermatol, 2011, 6(3):287-302.
3Liu P, Uziel Y, Chuang S, et al. Localized scleroderma: imaging features [J]. Pediatr Radiol, 1994, 24(3):207-209.
4Horger M, Fierlbeck G, Kuemmerle-Deschner J, et al. MRI findings in deep and generalized morphea(localized scleroderma) E J]. AJR Am J Roentgenol, 2008, 190(1):32-39.
5Peterson IS, Nelson AM, Su WP. Classification of morphea (localized scleroderma) [ J ]. Mayo Clin Proc, 1995, 70 (11) :1068-1076.
6Schanz S, Fierlbeck G, Ulmer A, et al. localized sclerodem~: MR findings and clinical features [ J]. Radiology, 2011, 260(3) :817-824.
7Careta MF, Leite CC, Cresta F, et al. Prospective study to evaluate the clinical and radiological outcome of patients with scleroderma of the face [J]. Autoimmun Rev, 2013, 12 ( 11 ) :1064-1069.
8Toledano C, Rabhi S, Kettaneh A, et al. I_ocalized scleroderma: a series of 52 patients [ J]. Eur J Intern Med, 2009, 20 (3) :331-336.
9Chini L, Orlacchio A, Silenzi R, et al. Neuroimaging is useful for monitoring disease activity in linear scleroderma "en coup de sabre" [J]. Minerva Pediatr, 2014, 66(1):89-93.
